Fitusiran meets primary endpoint in ATLAS-A/B trial Presented ByDr Alok Srivastava, Christian Medical College Vellore, India TrialPhase 3, ATLAS-A/B ConferenceASH 2021 4 February, 2022 10:50
ASH 2021 Highlights Podcast Presented ByDr Rachel Giles, Medicom ConferenceASH 2021 4 January, 2022 08:00